Table: Stella Pharma - 9-MTH parent results

Stella Pharma

10/02/2022 06:20

Feb 10 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2021        Dec 31, 2020      Mar 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            84 mln              155 mln           123 mln    
                 (-45.7 pct)                           (-40.3 pct)  
  Operating     loss 517 mln        loss 502 mln      loss 775 mln  
  Recurring     loss 557 mln        loss 502 mln      loss 827 mln  
  Net           loss 560 mln        loss 504 mln      loss 831 mln  
  EPS          loss 20.08 yen      loss 25.22 yen    loss 29.60 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T